The granulocyte-macrophage colony-stimulating factor (GM-CSF) analog E21R binds to the GM-CSF receptor complex with low affinity and acts as a competitive antagonist. In addition, it has been reported to be a potent direct activator of apoptosis in primary human acute myeloid leukemia (AML) cells. We have confirmed the ability of E21R to neutralize the biologic effects of GM-CSF and investigated its activity on primary AML blasts. We find that it failed to induce cell death in blast cells from 23 separate AML cases treated in vitro at concentrations of E21R up to 30 microg/mL. Significant cell death resulted in all cases after incubation with cytosine arabinoside. The lack of effect of E21R on AML blasts was unlikely to be due to an absence of functional GM-CSF receptors because 13 cases demonstrated an increase in cell number with the addition of exogenous GM-CSF. These results do not support the use of E21R for the treatment of AML.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2003-06-1985 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Predicting the effectiveness of omalizumab in patients with refractory chronic rhinosinusitis with nasal polyps comorbid with asthma based on inflammatory biomarkers.
World Allergy Organ J
January 2025
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Background: The treatment of refractory chronic rhinosinusitis with nasal polyps (CRSwNP) with omalizumab has been well studied based on clinical evaluation. Nevertheless, ideal quantitative or qualitative biomarkers for predicting a different response to biologics urgently need to be explored. We aim to identify potential biomarkers for predicting a good or poor response in patients with refractory CRSwNP.
View Article and Find Full Text PDFDevelopment of tetracycline analogues with increased aqueous stability for the treatment of mycobacterial infections.
Tuberculosis (Edinb)
January 2025
Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS#1000, Memphis, TN, 38105, USA. Electronic address:
Tetracycline analogs from the minocycline family have recently shown promise for the treatment of non-tuberculous mycobacterial infections. However, current tetracycline and minocycline therapeutics can be limited by tolerability, stability, or inactivation by TetX. In this study, a series of novel 9-heteroaryl substituted minocycline analogs were designed and synthesized, which resulted in analogs with good in vitro activity against Mycobacterium tuberculosis and Mycobacterium abscessus, stability in water for more than 7 days, avoidance of TetX inactivation in M.
View Article and Find Full Text PDFTherapeutic Strategies for Tuberculosis: Progress and Lessons Learned.
Biomed Environ Sci
November 2024
Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Article Synopsis
- * First-line treatments are being challenged by resistance, leading to the need for more toxic second-line drugs, but new agents and treatment regimens, like the BPaLM protocol, show promise for better efficacy and shorter treatment times.
- * Emerging strategies, including immunotherapy and cell therapies, aim to boost the immune response against TB, but significant obstacles remain in reaching the WHO's goal to end TB, especially due to resource diversion from the COVID-
β-integrins control HIF1α activation in human neutrophils.
Front Immunol
October 2024
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, Germany.
Article Synopsis
- Neutrophils use β-integrins to migrate to inflammation sites with low oxygen and high cytokine levels, and inhibiting prolyl hydroxylase domain-containing enzymes (PHDs) is thought to activate the HIF pathway in these cells.
- In experiments using PHD inhibitors or hypoxic conditions, researchers found that HIF1α protein accumulation occurs in adherent neutrophils, but not in suspended ones, highlighting the necessity of β-integrins for this process.
- The study revealed that β-integrins not only promote HIF1α mRNA translation through key factors, but also that activating HIF1α can delay neutrophil apoptosis, suggesting a vital role for this pathway in neutrophil survival
Anti-Inflammatory Immunomodulatory Activity of Valacyclovir on the Activated Mammalian Macrophages.
Discov Med
August 2024
Department of Biomedical Engineering, Faculty of Engineering and Life Sciences, Biruni University, 34015 Istanbul, Turkiye.
Article Synopsis
- Aciclovir and valacyclovir are antiviral agents, with valacyclovir being a prodrug of aciclovir, known for their effects against various herpesviruses like HHV-6 and HSV.
- The study involved treating activated mammalian macrophages with different concentrations of valacyclovir to assess its impact on inflammation by measuring pro-inflammatory cytokines like TNF-α and IL-6.
- Results indicated that valacyclovir exhibits anti-inflammatory properties, suggesting its potential use in clinical settings beyond just antiviral effects, while further research is needed on its effects on other immune cells.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!